Edwards Lifesciences Corp
Orthopedic, prosthetic & surgical appliances & supplies28 peers
- Last sale
- Nov 12, 2026 · +0.06%
- Market cap
- $60.88B
- 575M shares
- Filings
- 1,074
Q3 2026+11.5% FY25 yoy
Q3 2026−74.3% FY25 yoy
Q3 2026−8.3% FY25 yoy
Q3 2026derived+360.5% FY25 yoy
Q3 2026−73.7% FY25 yoy
Q3 2026−3.5% FY25 yoy
- $60.88B
- 59.6×
- 9.1×
- 5.6×
- 2.34%
- —
Twelve months to Sep 30, 2026 · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of record
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $6,067,600,000 | reported | |
| FY 2024 | 2024-12-31 | $5,439,500,000 | reported | |
| FY 2023 | 2023-12-31 | $5,010,000,000 revised | reported | |
| FY 2022 | 2022-12-31 | $4,464,000,000 revised | reported | |
| FY 2021 | 2021-12-31 | $5,232,500,000 | reported | |
| FY 2020 | 2020-12-31 | $4,386,300,000 | reported | |
| FY 2019 | 2019-12-31 | $4,348,000,000 | reported | |
| FY 2018 | 2018-12-31 | $3,722,800,000 | reported | |
| FY 2017 | 2017-12-31 | $3,435,300,000 | reported | |
| FY 2016 | 2016-12-31 | $2,963,700,000 | reported | |
| FY 2015 | 2015-12-31 | $2,493,700,000 | reported | |
| FY 2014 | 2014-12-31 | $2,322,900,000 | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2025 | — | $893.40M | $893.40M | — | 580.80M sh | −1.2% | 66.9% |
| FY2024 | — | $1.16B | $1.16B | — | 587.90M sh | −2.2% | 399.9% |
| FY2023 | — | $879.60M | $879.60M | — | 601.30M sh | −1.2% | 136.8% |
| FY2022 | — | $1.73B | $1.73B | — | 608.31M sh | −2.4% | 177.4% |
| FY2021 | — | $512.80M | $512.80M | — | 623.21M sh | −0.2% | 36.5% |
Segments
LineFY2025ShareChange
United States$3.54B58%+10.5%
Europe$1.52B25%+14.8%
Rest of World$652.30M11%+14.0%
Japan$354.70M5.8%+4.4%
Total$6.07B
Orthopedic, prosthetic & surgical appliances & supplies
Edwards Lifesciences Corp is the 4th largest of the 29 covered companies the SEC files under this code, by revenue. SIC 3842
CompanyRevenueGrowthNet marginMarket cap
ISRGIntuitive Surgical Inc$10.1B20.5%28.4%$152.5BZBHZimmer Biomet Holdings, Inc.$8.2B7.2%8.6%$19.8BSNNSmith & Nephew PLC$6.2B6.1%10.1%—
EWEdwards Lifesciences Corp (this company)$6.1B11.5%17.7%$60.9B
STESteris PLC$5.9B8.7%13.2%$24.6BALGNAlign Technology Inc$4.0B0.9%10.2%$11.8BENOVEnovis CORP$2.2B6.7%52.7%$1.6BMSAMSA Safety Inc$1.9B3.7%14.9%$6.7BCDRECadre Holdings, Inc.$610.3M7.5%7.2%$1.4BPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Edwards Lifesciences Corp · CIK 1099800 · Engraved from SEC EDGAR